scispace - formally typeset
A

Armin Reitmair

Researcher at Allergan

Publications -  21
Citations -  2263

Armin Reitmair is an academic researcher from Allergan. The author has contributed to research in topics: MSH2 & DNA mismatch repair. The author has an hindex of 16, co-authored 21 publications receiving 2193 citations. Previous affiliations of Armin Reitmair include French Institute of Health and Medical Research & University of Toronto.

Papers
More filters
Journal ArticleDOI

MSH2 deficient mice are viable and susceptible to lymphoid tumours.

TL;DR: A direct link between MSH2 deficiency and the pathogenesis of cancer is established and these mutant mice should be good models to study the progression of tumours and also to screen carcinogenic and anti–cancer agents.
Journal ArticleDOI

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL

TL;DR: Induction of TRAIL-mediated death signaling appears to contribute to the therapeutic value of retinoids in the leukemic blasts of freshly diagnosed acute promyelocytic leukemia patients.
Journal Article

MSH2 Deficiency Contributes to Accelerated APC-mediated Intestinal Tumorigenesis

TL;DR: Evidence is provided for the important role of MMR genes in accelerated intestinal tumorigenesis, thus supporting more aggressive surveillance strategies to prevent colorectal cancer in hereditary nonpolyposis coloreCTal cancer.
Journal Article

Spontaneous Intestinal Carcinomas and Skin Neoplasms in Msh2-deficient Mice

TL;DR: Tumor susceptibility of the recently described Msh2-deficient mouse model implicate a direct role for mismatch repair in several neoplasms with striking phenotypic similarities to humans.